315 related articles for article (PubMed ID: 27242236)
1. Treatment of severe refractory erythema nodosum leprosum with tumor necrosis factor inhibitor Etanercept.
Chowdhry S; Shukla A; D'souza P; Dhali T; Jaiswal P
Int J Mycobacteriol; 2016 Jun; 5(2):223-5. PubMed ID: 27242236
[TBL] [Abstract][Full Text] [Related]
2. Severe refractory erythema nodosum leprosum successfully treated with the tumor necrosis factor inhibitor etanercept.
Ramien ML; Wong A; Keystone JS
Clin Infect Dis; 2011 Mar; 52(5):e133-5. PubMed ID: 21292656
[TBL] [Abstract][Full Text] [Related]
3. Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-alpha) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL).
Sampaio EP; Moraes MO; Nery JA; Santos AR; Matos HC; Sarno EN
Clin Exp Immunol; 1998 Feb; 111(2):300-8. PubMed ID: 9486396
[TBL] [Abstract][Full Text] [Related]
4. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
de Carsalade GY; Achirafi A; Flageul B
Acta Leprol; 2003; 12(3):117-22. PubMed ID: 15040702
[TBL] [Abstract][Full Text] [Related]
5. Histoid leprosy complicated by erythema nodosum leprosum mimicking connective tissue disease.
Pal D
Trop Doct; 2023 Oct; 53(4):533-535. PubMed ID: 37401254
[TBL] [Abstract][Full Text] [Related]
6. T-cell regulation in Erythema Nodosum Leprosum.
Negera E; Walker SL; Bobosha K; Howe R; Aseffa A; Dockrell HM; Lockwood DN
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006001. PubMed ID: 28991896
[TBL] [Abstract][Full Text] [Related]
7. Erythema nodosum leprosum in a general hospital.
Rea TH; Levan NE
Arch Dermatol; 1975 Dec; 111(12):1575-80. PubMed ID: 1106330
[TBL] [Abstract][Full Text] [Related]
8. Etanercept in erythema nodosum leprosum.
Santos JRS; Vendramini DL; Nery JADC; Avelleira JCR
An Bras Dermatol; 2017; 92(4):575-577. PubMed ID: 28954119
[TBL] [Abstract][Full Text] [Related]
9. A study of serum fibrinolytic activity in erythema nodosum leprosum (ENL).
Jain VK; Verma KC; Aggarwal SS
Lepr India; 1983 Jan; 55(1):95-9. PubMed ID: 6876766
[TBL] [Abstract][Full Text] [Related]
10. Apremilast in chronic recalcitrant erythema nodosum leprosum: a report of two cases.
Narang T; Kaushik A; Dogra S
Br J Dermatol; 2020 Apr; 182(4):1034-1037. PubMed ID: 31218666
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Dilemma of Refractory Erythema Nodosum Leprosum.
Zhu J; Yang D; Shi C; Jing Z
Am J Trop Med Hyg; 2017 Jun; 96(6):1362-1364. PubMed ID: 28719256
[TBL] [Abstract][Full Text] [Related]
12. A retrospective study of the severe and uncommon variants of erythema nodosum leprosum at a tertiary health center in central India.
Wankhade VH; Debnath P; Singh RP; Sawatkar G; Bhat DM
Int J Mycobacteriol; 2019; 8(1):29-34. PubMed ID: 30860176
[TBL] [Abstract][Full Text] [Related]
13. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India.
Pocaterra L; Jain S; Reddy R; Muzaffarullah S; Torres O; Suneetha S; Lockwood DN
Am J Trop Med Hyg; 2006 May; 74(5):868-79. PubMed ID: 16687695
[TBL] [Abstract][Full Text] [Related]
14. Treatment of recurrent erythema nodosum leprosum with infliximab.
Faber WR; Jensema AJ; Goldschmidt WF
N Engl J Med; 2006 Aug; 355(7):739. PubMed ID: 16914716
[No Abstract] [Full Text] [Related]
15. The Effects of Prednisolone Treatment on Cytokine Expression in Patients with Erythema Nodosum Leprosum Reactions.
Negera E; Walker SL; Bobosha K; Bekele Y; Endale B; Tarekegn A; Abebe M; Aseffa A; Dockrell HM; Lockwood DN
Front Immunol; 2018; 9():189. PubMed ID: 29479352
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Efficacy and Safety of Ciclosporin to Prednisolone in the Treatment of Erythema Nodosum Leprosum: Two Randomised, Double Blind, Controlled Pilot Studies in Ethiopia.
Lambert SM; Nigusse SD; Alembo DT; Walker SL; Nicholls PG; Idriss MH; Yamuah LK; Lockwood DN
PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004149. PubMed ID: 26919207
[TBL] [Abstract][Full Text] [Related]
17. ENLIST 1: An International Multi-centre Cross-sectional Study of the Clinical Features of Erythema Nodosum Leprosum.
Walker SL; Balagon M; Darlong J; Doni SN; Hagge DA; Halwai V; John A; Lambert SM; Maghanoy A; Nery JA; Neupane KD; Nicholls PG; Pai VV; Parajuli P; Sales AM; Sarno E; Shah M; Tsegaye D; Lockwood DN;
PLoS Negl Trop Dis; 2015; 9(9):e0004065. PubMed ID: 26351858
[TBL] [Abstract][Full Text] [Related]
18. The effects of prednisolone treatment on serological responses and lipid profiles in Ethiopian leprosy patients with Erythema Nodosum Leprosum reactions.
Negera E; Tilahun M; Bobosha K; Lambert SM; Walker SL; Spencer JS; Aseffa A; Dockrell HM; Lockwood DN
PLoS Negl Trop Dis; 2018 Dec; 12(12):e0007035. PubMed ID: 30592714
[TBL] [Abstract][Full Text] [Related]
19. Localized and persistent erythema nodosum leprosum - a rare variant?
Prabhu S; Rao R; Sripathi H; Rao L; Singh R
Dermatol Online J; 2008 Mar; 14(3):16. PubMed ID: 18627717
[TBL] [Abstract][Full Text] [Related]
20. Low serum HDL-cholesterol is associated with raised tumor necrosis factor-alpha during ENL reactions.
Memon RA; Kifayet A; Shahid F; Lateef A; Chiang J; Hussain R
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):1-11. PubMed ID: 9207748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
